<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Alegre-Abarrategui J</submitter><funding>NIA NIH HHS</funding><funding>Medical Research Council</funding><funding>Network of Centres of excellence in Neurodegeneration</funding><funding>NIHR Imperial Biomedical Research Centre</funding><funding>Parkinson’s UK</funding><funding>Jean Shanks Foundation</funding><funding>National Institute on Aging</funding><funding>Michael J. Fox Foundation for Parkinson&amp;apos;s Research</funding><funding>Parkinson's UK</funding><pagination>681-704</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6800835</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>138(5)</volume><pubmed_abstract>Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy are neurodegenerative disorders resulting in progressive motor/cognitive deficits among other symptoms. They are characterised by stereotypical brain cell loss accompanied by the formation of proteinaceous aggregations of the protein α-synuclein (α-syn), being, therefore, termed α-synucleinopathies. Although the presence of α-syn inclusions is a common hallmark of these disorders, the exact nature of the deposited protein is specific to each disease. Different neuroanatomical regions and cellular populations manifest a differential vulnerability to the appearance of protein deposits, cell dysfunction, and cell death, leading to phenotypic diversity. The present review describes the multiple factors that contribute </pubmed_abstract><journal>Acta neuropathologica</journal><pubmed_title>Selective vulnerability in α-synucleinopathies.</pubmed_title><pmcid>PMC6800835</pmcid><funding_grant_id>P01 AG012411</funding_grant_id><funding_grant_id>J-0901</funding_grant_id><funding_grant_id>MR/P007058/1</funding_grant_id><funding_grant_id>J-1403</funding_grant_id><funding_grant_id>NIA AG12411</funding_grant_id><funding_grant_id>J-1402</funding_grant_id><pubmed_authors>Brimblecombe KR</pubmed_authors><pubmed_authors>Roberts RF</pubmed_authors><pubmed_authors>Tilley BS</pubmed_authors><pubmed_authors>Bengoa-Vergniory N</pubmed_authors><pubmed_authors>Alegre-Abarrategui J</pubmed_authors><pubmed_authors>Proukakis C</pubmed_authors><pubmed_authors>Velentza-Almpani E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Selective vulnerability in α-synucleinopathies.</name><description>Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy are neurodegenerative disorders resulting in progressive motor/cognitive deficits among other symptoms. They are characterised by stereotypical brain cell loss accompanied by the formation of proteinaceous aggregations of the protein α-synuclein (α-syn), being, therefore, termed α-synucleinopathies. Although the presence of α-syn inclusions is a common hallmark of these disorders, the exact nature of the deposited protein is specific to each disease. Different neuroanatomical regions and cellular populations manifest a differential vulnerability to the appearance of protein deposits, cell dysfunction, and cell death, leading to phenotypic diversity. The present review describes the multiple factors that contribute </description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Nov</publication><modification>2025-04-05T13:18:41.121Z</modification><creation>2019-11-09T08:00:50Z</creation></dates><accession>S-EPMC6800835</accession><cross_references><pubmed>31006067</pubmed><doi>10.1007/s00401-019-02010-2</doi></cross_references></HashMap>